UnitedHealth Group posted flat net income in Q4 2025 as a $1.6 billion after-tax charge impacted profitability. Adjusted earnings remained solid, while revenue rose compared to the prior year.

UnitedHealth Group delivered solid performance in Q3 2025, posting $113.2 billion in revenue and raising its full-year earnings outlook. While operating and net income declined compared to the prior year due to medical cost pressures, key segments like Optum Rx and UnitedHealthcare grew steadily.

UnitedHealth's Q2 2025 revenue grew to $111.6B, but net income dropped as the company faced $1.2B in discrete costs. EPS came in at $3.74 and adjusted EPS at $4.08. Growth was driven by UnitedHealthcare and Optum segments.

UnitedHealth Group delivered solid revenue and adjusted EPS growth in Q1 2025. However, unexpected increases in Medicare Advantage care activity and reimbursement shifts weighed on performance, prompting downward revisions to full-year guidance.

UnitedHealth Group reported an 8% year-over-year increase in revenues, reaching $400.3 billion for 2024. The company's Q4 net earnings were $5.98 per share, with adjusted net earnings at $6.81 per share. The growth was driven by serving more people extensively at Optum and UnitedHealthcare.

UnitedHealth Group reported Q3 2024 results with revenues of $100.8 billion, a year-over-year increase of $8.5 billion. The company's earnings per share (EPS) was $6.51, which included impacts from a cyberattack, and adjusted EPS was $7.15, which included $0.12 in business disruption impacts and excluded $0.28 in direct response costs. Growth was driven by an increase in the number of people served by Optum and UnitedHealthcare.

UnitedHealth Group reported Q2 2024 results with revenues of $98.9 billion, a $6 billion year-over-year increase led by Optum. Reported earnings were $4.54 per share, while adjusted earnings were $6.80 per share, including $0.28 in business disruption impacts. The company updated its full year 2024 net earnings outlook to $15.95 to $16.40 per share.

UnitedHealth Group's Q1 2024 revenues reached $99.8 billion, a year-over-year increase of nearly $8 billion. The company faced a net loss of $1.53 per share due to currency effects from the Brazil sale and the Change Healthcare cyberattack, which had a $0.74 per share impact. Adjusted earnings were $6.91 per share, including $0.25 in business disruption impacts from the cyberattack.

UnitedHealth Group's Q4 2023 revenues reached $94.4 billion, up from $82.8 billion year-over-year. The company reported net earnings of $5.83 per share and adjusted net earnings of $6.16 per share.

UnitedHealth Group's Q3 2023 revenues grew by 14% year-over-year to $92.4 billion, with earnings from operations increasing by 14% to $8.5 billion. Adjusted earnings per share were $6.56. The growth was driven by Optum and UnitedHealthcare.

UnitedHealth Group reported strong and well-balanced growth in the second quarter of 2023. Revenues reached $92.9 billion, a 16% year-over-year increase, and earnings from operations grew by 13%. The company has strengthened its full year net earnings outlook to $23.45 to $23.75 per share and adjusted net earnings to $24.70 to $25.00 per share.

UnitedHealth Group's first quarter 2023 revenues grew 15% to $91.9 billion year-over-year. Earnings from operations were $8.1 billion, a 16% increase. The company increased its full year net earnings outlook to $23.25 to $23.75 per share and adjusted net earnings to $24.50 to $25.00 per share.

UnitedHealth Group reported full year and fourth quarter 2022 results reflecting broad-based growth at Optum and UnitedHealthcare. Revenues of $324.2 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare. Full Year and Fourth Quarter Net Earnings were $21.18 and $5.03 Per Share and Adjusted Net Earnings were $22.19 and $5.34 Per Share.

UnitedHealth Group reported strong Q3 2022 results, with revenues reaching $80.9 billion, a 12% year-over-year increase. Earnings from operations grew by 31% to $7.5 billion, and adjusted net earnings per share increased by 28% to $5.79. The company has increased its full year 2022 net earnings outlook to $20.85 to $21.05 per share and adjusted net earnings to $21.85 to $22.05 per share.

UnitedHealth Group reported strong second-quarter results, with revenues reaching $80.3 billion, a 13% increase year-over-year. The growth was driven by Optum and UnitedHealthcare. Earnings per share were $5.34, and adjusted earnings per share were $5.57. The company has increased its full-year net earnings outlook to $20.45 to $20.95 per share and adjusted net earnings to $21.40 to $21.90 per share.

UnitedHealth Group reported strong first quarter 2022 results, with revenues of $80.1 billion, a 14% year-over-year increase. Earnings were $5.27 per share, and adjusted earnings were $5.49 per share. The company increased its full year net earnings outlook to $20.30 to $20.80 per share and adjusted net earnings to $21.20 to $21.70 per share.

UnitedHealth Group reported full year and fourth quarter 2021 results led by continued broad-based growth across the enterprise. Full Year and Fourth Quarter Net Earnings were $18.08 and $4.26 Per Share and Adjusted Net Earnings were $19.02 and $4.48 Per Share.

UnitedHealth Group reported strong third-quarter results with revenues increasing by 11% to $72.3 billion. The company's adjusted earnings per share were $4.52, and cash flows from operations were $7.6 billion. UnitedHealth Group increased its full year net earnings outlook to $17.70 to $17.95 per share and adjusted earnings to $18.65 to $18.90 per share.

UnitedHealth Group reported a 15% increase in revenues to $71.3 billion, driven by growth at Optum and UnitedHealthcare. Earnings from operations were $6.0 billion, and cash flows from operations reached $5.5 billion. Net earnings were $4.46 per share, and adjusted earnings were $4.70 per share.

UnitedHealth Group reported a strong first quarter with revenues of $70.2 billion, a 9% increase year-over-year, and earnings from operations growing by 35% to $6.7 billion. The company's performance was driven by balanced growth at both Optum and UnitedHealthcare. They also increased their full year net earnings outlook to $17.15 to $17.65 per share and adjusted earnings to $18.10 to $18.60 per share.

UnitedHealth Group reported Q4 2020 revenues of $65.5 billion and net earnings per share of $2.30. The results were impacted by COVID-19 care costs and related assistance initiatives. The company affirmed its full year earnings outlook for 2021.

UnitedHealth Group reported revenues of $65.1 billion, an 8% increase driven by Optum's 21% growth. Net earnings were $3.30 per share, and adjusted earnings were $3.51 per share. Results were impacted by consumer, customer, care provider, and community assistance initiatives related to COVID-19, though underlying business performance remained strong.

UnitedHealth Group's Q2 2020 revenues increased by $1.5 billion to $62.1 billion. Earnings from operations increased $4.5 billion to $9.2 billion, impacted primarily by deferred care in risk-based businesses. Net earnings per share was $6.91, and adjusted net earnings per share was $7.12.

UnitedHealth Group's first quarter 2020 revenues grew $4.1 billion or 6.8% to $64.4 billion. First quarter earnings from operations grew $164 million or 3.4% year-over-year to $5.0 billion. First quarter 2020 net earnings were $3.52 per share and adjusted net earnings were $3.72 per share.

UnitedHealth Group reported full year revenues of $242 billion, a growth of $16 billion or 7% year-over-year. The company's full year and fourth quarter net earnings per share were $14.33 and $3.68, growing 18% and 19% year-over-year, respectively. Full year and fourth quarter adjusted net earnings per share were $15.11 and $3.90, reflecting growth of 17% and 19% year-over-year. The company also reported full year cash flows from operations of $18.5 billion.